Advertisement

Organisation › Details
Lumicks Technologies B.V.
LUMICKS is a pioneering life science tools company dedicated to accelerating drug discovery in cancer research and advancing the understanding of fundamental biological mechanisms at the molecular and cellular levels. Our innovative technologies empower researchers to reveal crucial insights into the biological complexity of health and disease, driving the development of next-generation therapies and accelerating immunotherapy breakthroughs. Mission We empower academic and pharmaceutical communities with cutting-edge technologies to deeply understand the mechanisms of life and disease, driving the discovery and development of life-saving therapies. Vision By 2027, more than 250 world-leading researchers developing therapies and understanding biological mechanisms will use cell avidity and single-molecule data to develop cures that will impact more than 1 million lives. *
![]() |
Start | 2014-01-01 established (s-off) |
Group | Lumicks (Group) | |
Predecessor | Free University of Amsterdam (Vrije Universiteit Amsterdam) (VU) | |
![]() |
Industry | single molecule analysis |
Industry 2 | C-Trap® Optical Tweezers – Fluorescence Microscopy system | |
![]() |
Person | Heyning, Olivier (Lumicks –202104–202405 CEO LEFT 5/24) |
Person 2 | Wheeler, Paul (Lumicks 202107– CCO before Luminex + Merck + PRW Bioscience + Singulex + Gyros + Guava Technologies) | |
![]() |
Region | Amsterdam |
Country | Netherlands | |
Street | 41 Pilotenstraat | |
City | 1059 CH Amsterdam | |
Tel | +31-20-220-0817 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | D: 101 to 500 (2024-10-10) |
* Document for »About Section«: Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". | ||
Record changed: 2024-10-10 |
Advertisement

More documents for Lumicks (Group)
- [1] Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer"....
- [2] Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam....
- [3] Lumicks Technologies B.V.. (1/12/22). "Press Release: Lumicks Announces the Installation of its Quadruple C-Trap® Instrument at Rockefeller University to Expand Fundamental Research of DNA Processes". Amsterdam....
- [4] Lumicks Technologies B.V.. (8/17/21). "Press Release: Lumicks Appoints Paul Wheeler to Leadership Team as Chief Commercial Officer to Drive New Business Growth". Amsterdam....
- [5] Lumicks Technologies B.V.. (4/16/21). "Press Release: Lumicks Raises $93 Million in Series D Financing". Amsterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top